CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION

Clinical trials for CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION explained in plain language.

Never miss a new study

Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION trials appear

Sign up with your email to follow new studies for CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New transplant combo aims to tame Graft-Versus-Host disease

Disease control Ongoing

This study tests a stem cell transplant method for people with blood cancers like leukemia or lymphoma. The approach combines chemotherapy and radiation before transplant with a drug called cyclophosphamide after transplant to lower the risk of graft-versus-host disease, where do…

Matched conditions: CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION

Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control

Last updated May 01, 2026 15:58 UTC

CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION

Get alerted when new CHRONIC MYELOMONOCYTIC LEUKEMIA IN REMISSION trials appear

New transplant combo aims to tame Graft-Versus-Host disease